Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.63%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Long-Term Debt Issuances (2021)

Updated

Valion Bio (VBIO) posted Long-Term Debt Issuances of -$100,000 for Q4 2021.

Analysis

Valion Bio (VBIO) Long-Term Debt Issuances (2021) Analysis & Trends

For FY2021, Valion Bio's Long-Term Debt Issuances came in at $2.51 million.

  • According to Business Quant data, Long-Term Debt Issuances for the three prior quarters was $450,000 (Q3 2021), $1.75 million (Q2 2021) and $300,000 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Valion Bio 130,630.24 -19.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 450,000.00
Jun 30, 2021 1.75 Mn
Mar 31, 2021 300,000.00
API Access

Valion Bio Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VBIO&period=max&api_key=YOUR_API_KEY